Physician profile
Ray Keate
NPI 1679575609
$21,633.93
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,160 · 2020: $163 · 2021: $2,031 · 2022: $11K · 2023: $22.16 · 2024: $43.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $9,880.20 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $7,935.45 | 2019 | |
| Celgene Corporation | $3,243.64 | 2021-2022 | |
| Abbvie INC. | $227.79 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.23 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $101.08 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $29.28 | 2019-2021 | |
| Redhill Biopharma INC. | $22.76 | 2020 | |
| Boston Scientific Corporation | $17.50 | 2024 | Compliance Endokit |
| Conmed Corporation | $15.15 | 2024 | Conmed Generators, Conmed Dilation, Conmed Biliary |
| Pfizer INC. | $12.02 | 2019 | |
| Covidien LP | $11.86 | 2019 | |
| Olympus America INC. | $11.39 | 2019 | |
| Merit Medical Systems INC | $11.11 | 2024 | Endomaxx Stent and Delivery System, Alimaxx-Esophageal Stent/Delivery System |
| Qol Medical, LLC | $9.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Keate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.